Jacek Glinka is the President Europe for Mylan, one of the world’s leading global pharmaceutical companies, dedicated to providing the world’s 7 billion people access to high quality medicine, present in 38 countries in the European region and in approximately 145 countries and territories globally. He will assume the role of President of EGA in October 2015. He joined Mylan from the Polpharma Group, where he served as CEO from 2003 to 2006 and from 2009 to 2013. He began his professional career as a Strategic Management Consultant with firms including Deloitte & Touche and A.T. Kearney.